Literature DB >> 23194827

The cucurbitacins E, D and I: investigation of their cytotoxicity toward human chondrosarcoma SW 1353 cell line and their biotransformation in man liver.

Suzanne Abbas1, Jean-Baptiste Vincourt, Lamice Habib, Patrick Netter, Hélène Greige-Gerges, Jacques Magdalou.   

Abstract

Cucurbitacins are a class of natural compounds known for their numerous potential pharmacological effects. The purpose of this work was to compare the cytotoxicity of three cucurbitacins I, D, E on the chondrosarcoma SW 1353 cancer cell line and to investigate their biotransformation in man. Cucurbitacins I and D showed a very strong cytotoxicity, which was higher than that of cytochalasin D, used as a drug reference. Almost 100% of the cells were apoptotic as observed by DNA fragmentation (TUNEL assay) after 12 h with cucurbitacins I and D (1 μM) and cucurbitacin E (10 μM). In terms of IC(50) values, cucurbitacins I and E presented a higher toxicity compared to that of cucurbitacin D (MTT assay). Cucurbitacin E was readily hydrolyzed by human hepatic microsomes, leading to cucurbitacin I (K(m) 22 μM, V(max) 571 nmol/mg proteins/min). On the other hand, the three cucurbitacins were hydroxylated at a very low extent, but they were sulfated and glucuronidated. In terms of V(max)/K(m), the cucurbitacin E was the best substrate of UDP-glucuronosyltransferases. This study shows that cucurbitacins I, D and E present a potent cytotoxic activity toward the chondrosarcoma SW 1353 cell line and are metabolized as sulfate and glucuronide conjugates.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23194827     DOI: 10.1016/j.toxlet.2012.11.014

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  7 in total

1.  Cell-modified plasmonic interface for the signal-amplified detection of Cucurbitacin E.

Authors:  Yaofei Chen; Shuihua Peng; Peili Zhao; Lei Chen; Gui-Shi Liu; Dongyun Ouyang; Yunhan Luo; Zhe Chen
Journal:  Biomed Opt Express       Date:  2021-12-10       Impact factor: 3.732

Review 2.  Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds.

Authors:  Abedul Haque; Daniel Brazeau; Arm R Amin
Journal:  Eur J Cancer       Date:  2021-04-14       Impact factor: 9.162

3.  Cucurbitacins: elucidation of their interactions with the cytoskeleton.

Authors:  Xiaojuan Wang; Mine Tanaka; Herbenya Silva Peixoto; Michael Wink
Journal:  PeerJ       Date:  2017-05-30       Impact factor: 2.984

4.  Cucurbitacin E as inducer of cell death and apoptosis in human oral squamous cell carcinoma cell line SAS.

Authors:  Chao-Ming Hung; Chi-Chang Chang; Chen-Wei Lin; Shun-Yao Ko; Yi-Chiang Hsu
Journal:  Int J Mol Sci       Date:  2013-08-20       Impact factor: 5.923

5.  Inducement of mitosis delay by cucurbitacin E, a novel tetracyclic triterpene from climbing stem of Cucumis melo L., through GADD45γ in human brain malignant glioma (GBM) 8401 cells.

Authors:  Y-C Hsu; M-J Chen; T-Y Huang
Journal:  Cell Death Dis       Date:  2014-02-27       Impact factor: 8.469

6.  An updated review of Cucurbitacins and their biological and pharmacological activities.

Authors:  Sun Ok Chung; Yong Joo Kim; Sang Un Park
Journal:  EXCLI J       Date:  2015-05-05       Impact factor: 4.068

7.  Molecular genomic features associated with in vitro response of the NCI-60 cancer cell line panel to natural products.

Authors:  Julia Krushkal; Simarjeet Negi; Laura M Yee; Jason R Evans; Tanja Grkovic; Alida Palmisano; Jianwen Fang; Hari Sankaran; Lisa M McShane; Yingdong Zhao; Barry R O'Keefe
Journal:  Mol Oncol       Date:  2020-11-24       Impact factor: 7.449

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.